Qi Zheng

537 total citations
39 papers, 363 citations indexed

About

Qi Zheng is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Dermatology. According to data from OpenAlex, Qi Zheng has authored 39 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Dermatology. Recurrent topics in Qi Zheng's work include Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Qi Zheng is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Qi Zheng collaborates with scholars based in China, United States and Austria. Qi Zheng's co-authors include Bin Li, Matthew R. Reynolds, Gheorghe Doros, Xin Li, Xiaoying Sun, Tian Ma, Le Kuai, Wenbin Xu, Jiankun Song and Qiang Yan and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Qi Zheng

35 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Zheng China 11 112 106 60 52 46 39 363
Manjit Singh United States 5 37 0.3× 41 0.4× 46 0.8× 67 1.3× 69 1.5× 9 306
Haoyi Zheng United States 14 31 0.3× 79 0.7× 26 0.4× 153 2.9× 44 1.0× 33 509
Ilza Salamunić Croatia 13 36 0.3× 46 0.4× 12 0.2× 43 0.8× 21 0.5× 22 387
P. K. Nigam India 10 19 0.2× 59 0.6× 27 0.5× 70 1.3× 9 0.2× 19 386
Hayato Urushima Japan 10 63 0.6× 27 0.3× 8 0.1× 129 2.5× 15 0.3× 19 389
Eva Knuplez Austria 11 75 0.7× 47 0.4× 9 0.1× 166 3.2× 24 0.5× 14 395
Tuğba Mazlum Şen Türkiye 8 70 0.6× 9 0.1× 43 0.7× 105 2.0× 51 1.1× 11 389
Aliia R. Fatkhullina United States 5 218 1.9× 41 0.4× 10 0.2× 167 3.2× 27 0.6× 8 451
Tawee Laohapand Thailand 13 44 0.4× 12 0.1× 18 0.3× 73 1.4× 80 1.7× 35 435
José Luis Gálvez-Romero Mexico 9 91 0.8× 29 0.3× 13 0.2× 59 1.1× 134 2.9× 25 326

Countries citing papers authored by Qi Zheng

Since Specialization
Citations

This map shows the geographic impact of Qi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zheng more than expected).

Fields of papers citing papers by Qi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zheng. The network helps show where Qi Zheng may publish in the future.

Co-authorship network of co-authors of Qi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Zheng. A scholar is included among the top collaborators of Qi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Zheng. Qi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xie, Peitao, Yingli Liu, Yue Ming, et al.. (2025). TMEM132A: a novel susceptibility gene for lung adenocarcinoma combined with venous thromboembolism identified through comprehensive bioinformatic analysis. Frontiers in Oncology. 15. 1564114–1564114. 1 indexed citations
3.
Shan, Shan, Zeyu Liu, Shaoyang Wang, et al.. (2024). Isovalerylspiramycin I suppresses small cell lung cancer proliferation via ATR/CHK1 mediated DNA damage response and PERK/eIF2α/ATF4/CHOP mediated ER stress. Biochemical Pharmacology. 230(Pt 1). 116557–116557. 3 indexed citations
4.
Zheng, Qi, Xun Song, Ying Zhang, et al.. (2024). Qinzhuliangxue mixture ameliorates psoriasis by restraining apoptosis in psoriasis via downregulating the MDA-5 pathway. Journal of Ethnopharmacology. 328. 118059–118059. 3 indexed citations
6.
Song, Jiankun, Ying Zhang, Qi Zheng, et al.. (2024). The role and therapeutic strategies for tissue‐resident memory T cells, central memory T cells, and effector memory T cells in psoriasis. Immunology. 173(3). 470–480. 6 indexed citations
7.
Zheng, Qi, Huairui Yuan, Guangchuan Wang, et al.. (2024). Mitochondrial pyruvate carriers control airway basal progenitor cell function through glycolytic-epigenetic reprogramming. Cell stem cell. 32(1). 105–120.e6. 9 indexed citations
9.
Zheng, Qi, Zongguang Tai, Yue Luo, et al.. (2024). Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway. Phytomedicine. 128. 155412–155412. 12 indexed citations
10.
Zheng, Qi, et al.. (2023). Stochastic comparisons of the largest and smallest claim amounts with heterogeneous survival exponentiated location-scale distributed claim severities. Communication in Statistics- Theory and Methods. 53(21). 7541–7559. 1 indexed citations
11.
Wu, Xinxin, Qi Zheng, Jiankun Song, et al.. (2023). The therapeutic efficacy and mechanism action of Si Cao formula in the treatment of psoriasis: A pilot clinical investigation and animal validation. Journal of Ethnopharmacology. 323. 117662–117662. 4 indexed citations
12.
Ma, Xiaoxuan, Yue Luo, Qi Zheng, et al.. (2023). Rutin attenuates inflammation by downregulating AGE-RAGE signaling pathway in psoriasis: Network pharmacology analysis and experimental evidence. International Immunopharmacology. 125(Pt A). 111033–111033. 26 indexed citations
13.
Zheng, Qi, Le Kuai, Qiang Yan, et al.. (2022). Clinical Feature, Lifestyle Behavior and Non-Communicable Diseases Comorbidities Among Psoriasis Patients in Shanghai: Gender Disparity Analysis Based on a Cross-Sectional Study. Clinical Cosmetic and Investigational Dermatology. Volume 15. 2751–2762. 9 indexed citations
14.
Zheng, Qi, et al.. (2018). Association between physical activity and risk of prevalent psoriasis. Medicine. 97(27). e11394–e11394. 17 indexed citations
15.
Zheng, Qi, Melanie Maytin, Roy M. John, Ammar M. Killu, & Laurence M. Epstein. (2018). Transvenous lead extraction during uninterrupted warfarin therapy: Feasibility and outcomes. Heart Rhythm. 15(12). 1777–1781. 8 indexed citations
16.
Yan, Sijia, Fengmin Shao, Wen Zhang, et al.. (2018). HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions. The Pharmacogenomics Journal. 19(3). 277–285. 5 indexed citations
17.
Nakamura, Tomofumi, Ryohsuke Narui, Qi Zheng, et al.. (2018). Atrioventricular Block During Catheter Ablation for Ventricular Arrhythmias. JACC. Clinical electrophysiology. 5(1). 104–112. 8 indexed citations
18.
Killu, Ammar M., Nishaki Mehta, Qi Zheng, et al.. (2018). Endomyocardial biopsy at the time of ablation or device implantation. Journal of Interventional Cardiac Electrophysiology. 52(2). 163–169. 6 indexed citations
19.
Zheng, Qi, et al.. (2017). Validity of automated measurement of left ventricular ejection fraction and volume using the Philips EPIQ system. Echocardiography. 34(11). 1575–1583. 10 indexed citations
20.
Lanier, Gregg M., et al.. (2012). Simple prediction formula for peak oxygen consumption in patients with chronic heart failure. Journal of Exercise Science & Fitness. 10(1). 23–27. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026